BKV Corporation (BKV) Receives Buy Rating and $24 Price Target: Analyst Highlights ‘Closed-Loop’ System and Growth Potential

Truist Securities analyst Bertrand Donnes initiated coverage on BKV Corporation (BKV) with a Buy rating and a price target of $24, highlighting the company’s unique ‘closed-loop’ system and strong growth potential across its three segments. The analyst expects BKV to deliver on all three segments by 2025, with the company well-positioned to consolidate Barnett upstream assets, expand its Power JV into data center demand, and pursue larger CCUS projects.

Norfolk Southern (NSC) Stock Soars on Strong Q3 Results: Analyst Price Targets Rise

Norfolk Southern Corporation (NSC) shares have seen a surge in price targets following the company’s impressive third-quarter results. Several analysts have upgraded their ratings and increased their price targets on the stock, citing strong operational improvements and a positive outlook for the future. The company’s focus on operational efficiency, coupled with anticipated increases in shareholder returns and debt reduction, has fueled investor optimism.

Truist Initiates Coverage on Guardian Pharmacy Services (GRDN) with a ‘Buy’ Rating and $22 Price Target

Truist Securities has initiated coverage on Guardian Pharmacy Services (GRDN) with a ‘Buy’ rating and a price target of $22. The firm sees a sizable market opportunity for the company, which operates long-term care pharmacies, citing strong industry trends driven by the aging population and an increase in residents at assisted living facilities. Truist believes Guardian’s differentiated scale, suite of capabilities, and strategic market targeting make it well-positioned for growth.

Scroll to Top